Guiding the global evolution of cytogenetic testing for hematologic malignancies.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
14 04 2022
Historique:
received: 03 10 2021
accepted: 03 02 2022
pubmed: 16 2 2022
medline: 19 4 2022
entrez: 15 2 2022
Statut: ppublish

Résumé

Cytogenetics has long represented a critical component in the clinical evaluation of hematologic malignancies. Chromosome banding studies provide a simultaneous snapshot of genome-wide copy number and structural variation, which have been shown to drive tumorigenesis, define diseases, and guide treatment. Technological innovations in sequencing have ushered in our present-day clinical genomics era. With recent publications highlighting novel sequencing technologies as alternatives to conventional cytogenetic approaches, we, an international consortium of laboratory geneticists, pathologists, and oncologists, describe herein the advantages and limitations of both conventional chromosome banding and novel sequencing technologies and share our considerations on crucial next steps to implement these novel technologies in the global clinical setting for a more accurate cytogenetic evaluation, which may provide improved diagnosis and treatment management. Considering the clinical, logistic, technical, and financial implications, we provide points to consider for the global evolution of cytogenetic testing.

Identifiants

pubmed: 35167654
pii: S0006-4971(22)00210-5
doi: 10.1182/blood.2021014309
pmc: PMC9710485
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2273-2284

Informations de copyright

© 2022 by The American Society of Hematology.

Références

Blood Adv. 2020 May 26;4(10):2236-2244
pubmed: 32442300
Adv Wound Care (New Rochelle). 2013 Dec;2(10):583-587
pubmed: 24761332
Genes Chromosomes Cancer. 2013 Dec;52(12):1167-77
pubmed: 24123380
N Engl J Med. 2021 Jun 24;384(25):e106
pubmed: 34161718
Cold Spring Harb Mol Case Stud. 2019 Jun 3;5(3):
pubmed: 31160360
Genes Chromosomes Cancer. 2009 Oct;48(10):843-53
pubmed: 19582829
Nat Rev Genet. 2020 Oct;21(10):597-614
pubmed: 32504078
Blood Adv. 2020 Mar 10;4(5):930-942
pubmed: 32150610
Eur J Haematol. 2019 Jan;102(1):87-96
pubmed: 30270457
Leuk Res. 2013 Apr;37(4):416-21
pubmed: 23337401
Br J Haematol. 2020 Jan;188(1):36-48
pubmed: 31808952
Blood. 2011 Jun 23;117(25):6876-84
pubmed: 21527527
Genes Chromosomes Cancer. 2016 May;55(5):480-91
pubmed: 26774012
Cancer Genet. 2018 Dec;228-229:184-196
pubmed: 30393007
N Engl J Med. 2021 Jun 24;384(25):e106
pubmed: 34161719
Genet Med. 2021 Aug;23(8):1381-1390
pubmed: 34012068
Cancer Genet Cytogenet. 2010 Dec;203(2):134-40
pubmed: 21156225
J Mol Diagn. 2017 May;19(3):341-365
pubmed: 28341590
J Mol Diagn. 2020 Feb;22(2):284-293
pubmed: 31837433
Front Immunol. 2020 Oct 07;11:592087
pubmed: 33117405
Adv Wound Care (New Rochelle). 2013 Dec;2(10):576-582
pubmed: 24761331
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Blood. 2010 Apr 8;115(14):2731-9
pubmed: 20107230
Blood. 1985 Aug;66(2):380-90
pubmed: 3926026
Int J Mol Sci. 2019 Sep 23;20(19):
pubmed: 31547595
Haematologica. 2008 Jul;93(7):1001-8
pubmed: 18591625
Nat Commun. 2020 Sep 21;11(1):4748
pubmed: 32958763
Blood. 2019 Mar 14;133(11):1205-1216
pubmed: 30602617
Nat Commun. 2018 Sep 27;9(1):3962
pubmed: 30262806
Best Pract Res Clin Haematol. 2020 Sep;33(3):101196
pubmed: 33038985
Am J Clin Pathol. 2018 Mar 29;149(5):418-424
pubmed: 29538617
J Clin Oncol. 2019 Jan 20;37(3):239-253
pubmed: 30523709
Nature. 2020 Sep;585(7823):79-84
pubmed: 32663838
Sci Rep. 2019 Mar 26;9(1):5179
pubmed: 30914738
J Mol Diagn. 2021 Jul;23(7):784-787
pubmed: 34020043
Curr Hematol Malig Rep. 2020 Jun;15(3):194-202
pubmed: 32382988
Leukemia. 2019 Aug;33(8):1851-1867
pubmed: 30696948
Science. 2004 Jul 23;305(5683):525-8
pubmed: 15273396
Blood. 2017 Jul 27;130(4):410-423
pubmed: 28600336
Blood Cancer J. 2013 Jul 19;3:e127
pubmed: 23872706
J Clin Oncol. 2021 Apr 10;39(11):1223-1233
pubmed: 33539200
Bioinformatics. 2016 Apr 15;32(8):1220-2
pubmed: 26647377
Genet Med. 2018 Oct;20(10):1122-1130
pubmed: 29446766
Nature. 2020 May;581(7809):444-451
pubmed: 32461652
Genes Chromosomes Cancer. 2021 Oct;60(10):657-667
pubmed: 33982372
Nat Commun. 2021 Jun 17;12(1):3705
pubmed: 34140493
Clin Cancer Res. 2021 Oct 1;27(19):5430-5439
pubmed: 34233962
Nat Rev Genet. 2016 May 17;17(6):333-51
pubmed: 27184599
Br J Haematol. 2009 Sep;146(5):479-88
pubmed: 19563474
Am J Clin Pathol. 2016 Jul;146(1):86-94
pubmed: 27353768
Oncotarget. 2015 Aug 7;6(22):18845-62
pubmed: 26299921
Blood. 2012 Sep 20;120(12):2454-65
pubmed: 22740453
Br J Haematol. 2020 Mar;188(5):605-622
pubmed: 31621063
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7689-94
pubmed: 26056298
Front Oncol. 2019 Sep 04;9:851
pubmed: 31552176
Science. 1991 Nov 22;254(5035):1153-60
pubmed: 1957167
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Am J Hum Genet. 2021 Aug 5;108(8):1423-1435
pubmed: 34237281
Nat Rev Clin Oncol. 2021 Sep;18(9):543-544
pubmed: 34011977
Cancer. 1992 Sep 15;70(6 Suppl):1701-9
pubmed: 1516024
Nat Commun. 2020 May 29;11(1):2666
pubmed: 32471990
Eur J Hum Genet. 2014 May;22(5):652-9
pubmed: 24105367
J Mol Diagn. 2021 Jul;23(7):816-833
pubmed: 33964451
Nature. 2018 Oct;562(7728):526-531
pubmed: 30333627
Blood. 2007 Nov 1;110(9):3365-73
pubmed: 17634407
J Pers Med. 2014 Apr 04;4(2):163-75
pubmed: 25563222
Eur J Haematol. 2018 Sep;101(3):260-271
pubmed: 29742289
J Cell Physiol. 1977 Jun;91(3):335-44
pubmed: 301143
Haematologica. 2019 Jun;104(6):e248-e251
pubmed: 30523057
Hematol Oncol Clin North Am. 2009 Oct;23(5):991-1010, v
pubmed: 19825449
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Leukemia. 2020 Jan;34(1):306-311
pubmed: 31435024
J Mol Diagn. 2017 Jan;19(1):4-23
pubmed: 27993330
Cancer Genet. 2020 May;243:48-51
pubmed: 32272434
PLoS One. 2020 Sep 28;15(9):e0239850
pubmed: 32986766
Cancer Genet. 2018 Dec;228-229:236-250
pubmed: 30554732
Cancer Discov. 2021 Nov;11(11):2846-2867
pubmed: 34103329
J Clin Oncol. 2012 Mar 10;30(8):820-9
pubmed: 22331955
J Mol Diagn. 2021 Apr;23(4):455-466
pubmed: 33486075
Genet Med. 2019 Sep;21(9):1903-1916
pubmed: 31138931
Genome Med. 2010 Nov 26;2(11):84
pubmed: 21114804
BMC Bioinformatics. 2017 May 31;18(1):286
pubmed: 28569140
N Engl J Med. 2021 Mar 11;384(10):924-935
pubmed: 33704937
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Genome Med. 2017 Oct 25;9(1):90
pubmed: 29070057
Blood. 2011 Apr 28;117(17):4552-60
pubmed: 21285439
Cancer Genet. 2018 Dec;228-229:197-217
pubmed: 30377088
Nat Commun. 2021 Apr 30;12(1):2474
pubmed: 33931648
Expert Rev Mol Diagn. 2014 Jul;14(6):699-712
pubmed: 24938122
Mutat Res. 2000 Apr;462(2-3):247-53
pubmed: 10767636
Cancer Genet. 2020 Apr;242:15-24
pubmed: 31980417
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Blood. 2019 Mar 7;133(10):1049-1059
pubmed: 30670442
Lancet Oncol. 2020 Mar;21(3):e168-e178
pubmed: 32135120
Nat Genet. 2004 Sep;36(9):949-51
pubmed: 15286789
Cytogenet Cell Genet. 1983;36(1-2):1-515
pubmed: 6627995
N Engl J Med. 2021 Jun 24;384(25):e106
pubmed: 34161717
Nucleic Acids Res. 2014 Jan;42(Database issue):D986-92
pubmed: 24174537
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Am J Clin Pathol. 2015 Jun;143(6):873-8
pubmed: 25972330
Am J Clin Pathol. 2011 Jun;135(6):915-20
pubmed: 21571964
Mod Pathol. 2020 Mar;33(3):334-343
pubmed: 31471587
Blood. 2007 Dec 15;110(13):4385-95
pubmed: 17726160
Cancer Genet. 2020 May;243:52-72
pubmed: 32302940
Blood Cancer Discov. 2020 Nov;1(3):258-273
pubmed: 33392515
Hematology Am Soc Hematol Educ Program. 2006;:169-77
pubmed: 17124057
Hum Mutat. 2012 Jun;33(6):941-8
pubmed: 22488943
N Engl J Med. 2019 Nov 28;381(22):2145-2156
pubmed: 31774959
Blood Cancer J. 2019 Dec 16;9(12):103
pubmed: 31844041
Nat Med. 2020 Oct;26(10):1549-1556
pubmed: 32747829
Blood. 2007 Apr 15;109(8):3189-97
pubmed: 17170120
Blood. 1986 Sep;68(3):790-3
pubmed: 3461854
BMC Health Serv Res. 2020 Jun 3;20(1):492
pubmed: 32493298
Sci Rep. 2020 Feb 13;10(1):2512
pubmed: 32054878
Methods Mol Biol. 2017;1541:223-245
pubmed: 27910027
BMC Med Genomics. 2015 Oct 15;8:64
pubmed: 26470712
Genes Chromosomes Cancer. 1992 Jul;5(1):57-66
pubmed: 1384663
Nat Genet. 2008 Jun;40(6):685-6
pubmed: 18509307
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766

Auteurs

Yassmine M N Akkari (YMN)

Departments of Cytogenetics and Molecular Pathology, Legacy Health, Portland, OR.

Linda B Baughn (LB)

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Adrian M Dubuc (AM)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Adam C Smith (AC)

Laboratory Medicine Program, University Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

Mar Mallo (M)

MDS Group, Microarrays Unit, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.

Paola Dal Cin (P)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Maria Diez Campelo (M)

Hematology Department University Hospital of Salamanca, IBSAL, Salamanca, Spain.

Marta S Gallego (MS)

Laboratory of Cytogenetics and Molecular Cytogenetics, Department of Clinical Pathology, Italian Hospital, Buenos Aires, Argentina.

Isabel Granada Font (I)

Hematology Laboratory, Germans Trias i Pujol University Hospital-Catalan Institute of Oncology, Josep Carreras Leukemia Research Institute, Barcelona, Spain.

Detlef T Haase (DT)

Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.

Brigitte Schlegelberger (B)

Department of Human Genetics, Hannover Medical School, Hannover, Germany.

Irma Slavutsky (I)

Laboratory Genetics of Lymphoid Malignancies, Institute of Experimental Medicine, Buenos Aires, Argentina.

Cristina Mecucci (C)

Laboratory of Cytogenetics and Molecular Medicine, Hematology University of Perugia, Perugia, Italy.

Ross L Levine (RL)

Department of Medicine, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY.

Robert P Hasserjian (RP)

Department of Pathology, Massachusetts General Hospital, Boston, MA; and.

Francesc Solé (F)

MDS Group, Microarrays Unit, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.

Brynn Levy (B)

College of Physicians and Surgeons, Columbia University Medical Center and the New York Presbyterian Hospital, New York, NY.

Xinjie Xu (X)

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH